These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7615001)

  • 1. TAP1-independent loading of class I molecules by exogenous viral proteins.
    Bachmann MF; Oxenius A; Pircher H; Hengartner H; Ashton-Richardt PA; Tonegawa S; Zinkernagel RM
    Eur J Immunol; 1995 Jun; 25(6):1739-43. PubMed ID: 7615001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
    Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P
    Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protective cytotoxic T cells with viral proteins.
    Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
    Harding CV; Song R
    J Immunol; 1994 Dec; 153(11):4925-33. PubMed ID: 7963555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of herpes simplex virus gB-specific cytotoxic T lymphocytes in TAP1-deficient mice by genetic immunization but not HSV infection.
    Paliard X; Doe B; Selby MJ; Hartog K; Lee AY; Burke RL; Walker CM
    Virology; 2001 Mar; 282(1):56-64. PubMed ID: 11259190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Sigal LJ; Crotty S; Andino R; Rock KL
    Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
    Shen Z; Reznikoff G; Dranoff G; Rock KL
    J Immunol; 1997 Mar; 158(6):2723-30. PubMed ID: 9058806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
    Rawson P; Hermans IF; Huck SP; Roberts JM; Pircher H; Ronchese F
    Cancer Res; 2000 Aug; 60(16):4493-8. PubMed ID: 10969797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
    Wick MJ; Pfeifer JD
    Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
    Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
    Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo.
    Shen L; Sigal LJ; Boes M; Rock KL
    Immunity; 2004 Aug; 21(2):155-65. PubMed ID: 15308097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus evasion of MHC class I molecule presentation.
    Petersen JL; Morris CR; Solheim JC
    J Immunol; 2003 Nov; 171(9):4473-8. PubMed ID: 14568919
    [No Abstract]   [Full Text] [Related]  

  • 19. The evolving biology of cross-presentation.
    Ohara RA; Murphy KM
    Semin Immunol; 2023 Mar; 66():101711. PubMed ID: 36645993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-like particle vaccinology, from bench to bedside.
    Mohsen MO; Bachmann MF
    Cell Mol Immunol; 2022 Sep; 19(9):993-1011. PubMed ID: 35962190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.